{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04822363",
            "orgStudyIdInfo": {
                "id": "2021-P-000134"
            },
            "organization": {
                "fullName": "Beth Israel Deaconess Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry",
            "officialTitle": "The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry",
            "therapeuticArea": [
                "Other"
            ],
            "study": "the-accuracy-of-a-novel-platelet-activity-assay-in-humans-on-antiplatelet-agents-pharmacodynamics-and-comparison-with-light-transmission-aggregometry"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-08-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-03-26",
            "studyFirstSubmitQcDate": "2021-03-26",
            "studyFirstPostDateStruct": {
                "date": "2021-03-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-03-31",
            "lastUpdatePostDateStruct": {
                "date": "2022-04-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jeff Zwicker",
                "investigatorTitle": "Attending Physician, Associate Professor",
                "investigatorAffiliation": "Beth Israel Deaconess Medical Center"
            },
            "leadSponsor": {
                "name": "Beth Israel Deaconess Medical Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                },
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to test a novel diagnostic immunoassay of platelet function and compare it to the current gold standard platelet function assay by testing the response to aspirin and clopidogrel in a group of healthy volunteers and severely obese individuals and comparing the accuracy of the two tests. The secondary goals will be to evaluate the pharmacodynamic parameters of the antiplatelet agents across the two testing modalities and refine the cutoffs used for the novel assay."
        },
        "conditionsModule": {
            "conditions": [
                "Platelet Activation Testing Before/After Anti-platelet Therapy",
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 125,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group A: Healthy",
                    "type": "EXPERIMENTAL",
                    "description": "Low Dose Aspirin - 81mg daily for 7 days",
                    "interventionNames": [
                        "Drug: Aspirin"
                    ]
                },
                {
                    "label": "Group B: Healthy",
                    "type": "EXPERIMENTAL",
                    "description": "High Dose Aspirin - 325mg daily for 7 days",
                    "interventionNames": [
                        "Drug: Aspirin"
                    ]
                },
                {
                    "label": "Group C: Healthy",
                    "type": "EXPERIMENTAL",
                    "description": "Clopidogrel 300mg on Day 1 and 75mg daily for 6 subsequent days",
                    "interventionNames": [
                        "Drug: Clopidogrel"
                    ]
                },
                {
                    "label": "Group D: Obese",
                    "type": "EXPERIMENTAL",
                    "description": "Low Dose Aspirin - 81mg daily for 7 days",
                    "interventionNames": [
                        "Drug: Aspirin"
                    ]
                },
                {
                    "label": "Group E: Obese",
                    "type": "EXPERIMENTAL",
                    "description": "Clopidogrel 300mg on Day 1 and 75mg daily for 6 subsequent days",
                    "interventionNames": [
                        "Drug: Clopidogrel"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Aspirin",
                    "description": "Low dose aspirin in Arms A and D and High Dose Aspirin in Arm B",
                    "armGroupLabels": [
                        "Group A: Healthy",
                        "Group B: Healthy",
                        "Group D: Obese"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Clopidogrel",
                    "description": "Arms C and E",
                    "armGroupLabels": [
                        "Group C: Healthy",
                        "Group E: Obese"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Comparison at day 5 of pDrp1 Assay relative to Light Transmission Aggregometry",
                    "description": "Sensitivity of pDrp1 assay for platelet inhibition at day 5",
                    "timeFrame": "5 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Subject is \u226518 years of age\n2. Subject is willing to participate and provide informed consent\n3. Subject is considered reliable and capable of adhering to the protocol per the judgment of the Investigator\n4. Groups A, B and C: BMI \\< 30 kg/m2; Groups D and E: BMI \u2265 35 kg/m2\n5. Subjects must be age \u2265 18 years old\n6. Serum Creatinine \\< 1.5 mg/dL\n7. Platelet count \u2265 150 K/uL\n8. Hematocrit \u2265 38%\n\nExclusion Criteria:\n\n1. Pregnant. If female of child-bearing age, negative urinary pregnancy test required at time of enrollment. Women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman become pregnant or suspect she is pregnant she should inform her treating physician immediately.\n2. Established diagnosis of cirrhosis or active cancer\n3. History of allergy to aspirin or clopidogrel\n4. Any history of taking aspirin, antiplatelet drugs, NSAIDS, cyclooxygenase (COX)-2 inhibitors, warfarin, low-molecular weight heparin, thrombolytic agents, or other anticoagulants (such as direct thrombin inhibitors or factor X inhibitors) within 2 weeks prior to enrollment. (Refer to appendix)\n5. Use of certain antibiotics, cardiovascular drugs, lipid-lowering agents, antidepressants, antihistamines, non-prescription drugs, and supplements within the past 2 weeks. (Refer to appendix)\n6. Any major illness requiring hospitalization or surgery in the previous six months.\n7. Personal history of gastrointestinal bleed in the last 24 months or diagnosis of peptic ulcer disease in the last 12 months\n8. Lifetime personal history of hemorrhagic stroke.\n9. Personal or family history of bleeding diatheses, including hemophilias, von Willebrand's disease, Bernard-Soulier syndrome, or Glanzmann thrombasthenia (unless otherwise confirmed not present in study subject)",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jeffrey Zwicker, MD",
                    "role": "CONTACT",
                    "phone": "617-667-9920",
                    "email": "jzwicker@bidmc.harvard.edu"
                },
                {
                    "name": "Pavania Elavalakanar, MSc",
                    "role": "CONTACT",
                    "phone": "617-667-1903",
                    "email": "pelavala@bidmc.harvard.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Beth Israel Deaconess Medical Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jeffrey Zwicker, MD",
                            "role": "CONTACT",
                            "phone": "617-667-9920",
                            "email": "jzwicker@bidmc.harvard.edu"
                        },
                        {
                            "name": "Pavania Elavalakanar, MSc",
                            "role": "CONTACT",
                            "phone": "617-667-1903",
                            "email": "pelavala@bidmc.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001241",
                    "term": "Aspirin"
                },
                {
                    "id": "D000077144",
                    "term": "Clopidogrel"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000894",
                    "term": "Anti-Inflammatory Agents, Non-Steroidal"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000005343",
                    "term": "Fibrinolytic Agents"
                },
                {
                    "id": "D000050299",
                    "term": "Fibrin Modulating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000010975",
                    "term": "Platelet Aggregation Inhibitors"
                },
                {
                    "id": "D000016861",
                    "term": "Cyclooxygenase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000058633",
                    "term": "Antipyretics"
                },
                {
                    "id": "D000058921",
                    "term": "Purinergic P2Y Receptor Antagonists"
                },
                {
                    "id": "D000058919",
                    "term": "Purinergic P2 Receptor Antagonists"
                },
                {
                    "id": "D000058914",
                    "term": "Purinergic Antagonists"
                },
                {
                    "id": "D000058905",
                    "term": "Purinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1669",
                    "name": "Clopidogrel",
                    "asFound": "Services",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4548",
                    "name": "Aspirin",
                    "asFound": "Vitamin",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13865",
                    "name": "Platelet Aggregation Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4218",
                    "name": "Anti-Inflammatory Agents, Non-Steroidal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M8473",
                    "name": "Fibrinolytic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M19209",
                    "name": "Cyclooxygenase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29176",
                    "name": "Antipyretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M29294",
                    "name": "Purinergic P2Y Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PlAggInh",
                    "name": "Platelet Aggregation Inhibitors"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Antipy",
                    "name": "Antipyretics"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "FiAg",
                    "name": "Fibrinolytic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                }
            ]
        }
    },
    "hasResults": false
}